Significance of circulating tumor cells in metastatic triple negative breast cancer: Results of an open label, randomized, phase II trial of nanoparticle albumin-bound paclitaxel with or without the anti-death receptor 5 tigatuzumab (TBCRC 019) Meeting Abstract
| Authors: | Paoletti, C.; Li, Y.; Muñiz, M. C.; Kidwell, K. M.; Aung, K.; Thomas, D. G.; Brown, M. E.; Abramson, V.; Irvin, W. J. Jr; Lin, N. U.; Liu, M.; Nanda, R.; Nangia, J.; Storniolo, A. M.; Traina, T. A.; Vaklavas, C.; Van Poznak, C. H.; Wolff, A. C.; Forero, A.; Hayes, D. F. |
| Abstract Title: | Significance of circulating tumor cells in metastatic triple negative breast cancer: Results of an open label, randomized, phase II trial of nanoparticle albumin-bound paclitaxel with or without the anti-death receptor 5 tigatuzumab (TBCRC 019) |
| Meeting Title: | 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 73 |
| Issue: | 24 Suppl. |
| Meeting Dates: | 2013 Dec 10-14 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2013-12-15 |
| Language: | English |
| ACCESSION: | WOS:000209496900139 |
| DOI: | 10.1158/0008-5472.sabcs13-p1-04-01 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P1-04-01 -- Source: Wos |
